Document Detail


Intracardiac injection of matrigel induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model.
MedLine Citation:
PMID:  20477905     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Matrigel promotes angiogenesis in the myocardium from ischemic injury and prevents remodelling of the left ventricle. We assessed the therapeutic efficacy of intracardiac matrigel injection and matrigel-mediated stem cell homing in a rat myocardial infarction (MI) model. Following MI, matrigel (250 μl) or phosphate-buffered solution (PBS) was delivered by intracardiac injection. Compared to the MI control group (MI-PBS), matrigel significantly improved left ventricular function (n= 11, P < 0.05) assessed by pressure-volume loops after 4 weeks. There is no significant difference in infarct size between MI-matrigel (MI-M; 21.48 ± 1.49%, n = 10) and MI-PBS hearts (20.98 ± 1.25%, n = 10). The infarct wall thickness of left ventricle is significantly higher (P < 0.01) in MI-M (0.72 ± 0.02 mm, n = 10) compared with MI-PBS (0.62 ± 0.02 mm, n = 10). MI-M hearts exhibited higher capillary density (border 130.8 ± 4.7 versus 115.4 ± 6.0, P < 0.05; vessels per high-power field [HPF; 400×], n = 6) than MI-PBS hearts. c-Kit(+) stem cells (38.3 ± 5.3 versus 25.7 ± 1.5 c-Kit(+) cells per HPF [630×], n = 5, P < 0.05) and CD34(+) cells (13.0 ± 1.51 versus 5.6 ± 0.68 CD34(+) cells per HPF [630×], n = 5, P < 0.01) were significantly more numerous in MI-M than in MI-PBS in the infarcted hearts (n = 5, P < 0.05). Intracardiac matrigel injection restores myocardial functions following MI, which may attribute to the improved recruitment of CD34(+) and c-Kit(+) stem cells.
Authors:
Lailiang Ou; Wenzhong Li; Yue Zhang; Weiwei Wang; Jun Liu; Heiko Sorg; Dario Furlani; Ralf Gäbel; Peter Mark; Christian Klopsch; Liang Wang; Karola Lützow; Andreas Lendlein; Klaus Wagner; Doris Klee; Andreas Liebold; Ren-Ke Li; Deling Kong; Gustav Steinhoff; Nan Ma
Related Documents :
2880685 - Therapeutic trends in the management of patients with acute myocardial infarction (1975...
17296595 - Elevated factor xiii level and the risk of myocardial infarction in women.
24775505 - Cardiovascular risk factors and lifestyle associated with premature myocardial infarcti...
18694365 - Myocardial infarction, heart failure and sympathetic nervous system activity: new pharm...
15875095 - Icd therapy in coronary artery disease. a reappraisal in 2005.
3740085 - Diabetes mellitus for 25 years or more. analysis of cardiovascular findings in seven pa...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-14
Journal Detail:
Title:  Journal of cellular and molecular medicine     Volume:  15     ISSN:  1582-4934     ISO Abbreviation:  J. Cell. Mol. Med.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101083777     Medline TA:  J Cell Mol Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  1310-8     Citation Subset:  IM    
Copyright Information:
© 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.
Affiliation:
Reference- and Translation Center for Cardiac Stem Cell Therapy (RTC), Department of Cardiac Surgery, University of Rostock, Rostock, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Peritoneal repairing cells: a type of bone marrow derived progenitor cells involved in mesothelial r...
Next Document:  Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through ac...